Mitral Regurgitation Functional clinical trials at UC Davis

1 research study open to eligible people

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
open to eligible people ages 21 years and up
Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.
Sacramento, California and other locations

Last updated: July 27, 2026